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ABSTRACT 
The class 2 type VI CRISPR Cas13 systems, an RNA targeting CRISPR-Cas effector, has been originally involved in 
adaptive prokaryotic immunity by protecting bacteria against invading RNA phages, It is currently used as a tool to cut 
and degrade RNA in a precise manner in yeasts, mammalian and plant cell lines. In the Moreno-Mateos lab the CRISPR-
RfxCas13d system has been recently shown as an efficient and specific system in zebrafish and other models targeting 
mRNA in animal embryos (Kushawah et al., Biorxiv 2020). Our lab is interested in understanding an early 
embryogenesis process called the maternal-to-zygotic transition (MZT). This process implies the activation of a silent 
embryonic genome by the maternal mRNA products deposited in the oocyte. We have used our CRISPR-Cas13d 
technology to knockdown mRNAs from the maternal contribution with a role in the zygotic genome activation (ZGA). 
For example, we injected mRNA coding Cas13d and gRNAs targeting nanog, a maternally-provided factor crucial for 
the ZGA, and we observed classical phenotypes when MZT is altered. However, we found that the penetrance of the 
targeting and the observed knockdown phenotypes can be optimized. To achieve this, we reasoned that the injection 
of the purified protein instead the mRNA coding Cas13d could have an earlier targeting of these and other maternal 
RNAs. 
In this work, we have generated a bacterial expression vector and successfully purified RfxCas13d endonuclease. The 
RfxCas13d protein was expressed in E. coli cells and purified by affinity and ion-exchange chromatography methods. 
In vivo tests in zebrafish embryos demonstrate that the purified protein is biologically active and the complex Cas13-
gRNA triggers efficient mRNA knock-down showing higher targeting RNA depletion than injections of Cas13 mRNA. 
We are currently analysing the specificity of the Cas13d protein in vivo by RNAseq experiments and performing in vitro 
cleavage assays to complement the results obtained in vivo. 
All together, these results demonstrate that the use of purified protein for maternal RNA targeting is an efficient and 
convenient system to potentially uncover novel maternal RNA functions. This new optimized tool will open up new 
avenues that will illuminate our knowledge in early vertebrate embryogenesis. 
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